Search Results

Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis

Authors: Albertson, Timothy E; Chan, Andrew L

Source: Expert Review of Respiratory Medicine, Volume 3, Number 5, October 2009 , pp. 539-548(10)

Publisher: Expert Reviews

Treatment of acute bacterial exacerbations of chronic bronchitis

Authors: Siempos, Ilias I; Michalopoulos, Argyris; Falagas, Matthew E

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 7, May 2009 , pp. 1173-1182(10)

Publisher: Informa Healthcare

Contribution of a shelter-based survey for screening respiratory diseases in the homeless

Authors: Badiaga, Sékéné; Richet, Hervé; Azas, Patricia; Zandotti, Christine; Rey, Françoise; Charrel, Rémi; Benabdelkader, El-hadi; Drancourt, Michel; Raoult, Didier; Brouqui, Philippe

Source: European Journal of Public Health, Volume 19, Number 2, 5 April 2009 , pp. 157-160(4)

Publisher: Oxford University Press

Positive Predictive Value of ICD-9-CM Codes to Detect Acute Exacerbation of COPD in the Emergency Department

Authors: Ginde, Adit A.; Tsai, Chu-Lin; Blanc, Phillip G.; Camargo, Carlos A.

Source: Joint Commission Journal on Quality and Patient Safety, Volume 34, Number 11, November 2008 , pp. 678-680(3)

Publisher: Joint Commission Resources

Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease

Author: Moretti, Maurizio

Source: Expert Review of Respiratory Medicine, Volume 1, Number 3, December 2007 , pp. 307-316(10)

Publisher: Expert Reviews

Pharmacoeconomics of the management of acute exacerbations of chronic obstructive pulmonary disease

Authors: Simoens, Steven; Decramer, Marc

Source: Expert Opinion on Pharmacotherapy, Volume 8, Number 5, April 2007 , pp. 633-648(16)

Publisher: Informa Healthcare

Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections

Authors: Sader, Helio S; Jones, Ronald N

Source: Expert Review of Anti-Infective Therapy, Volume 5, Number 1, February 2007 , pp. 29-43(15)

Publisher: Expert Reviews

Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis

Authors: Gotfried, Mark; Busman, Todd A.; Norris, Sandra; Notario, Gerard F.

Source: Current Medical Research and Opinion, Volume 23, Number 2, February 2007 , pp. 459-466(8)

Publisher: Informa Healthcare

Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity

Authors: Kahn, James B.; Khashab, Mohammed; Ambruzs, Mary

Source: Current Medical Research and Opinion, Volume 23, Number 1, January 2007 , pp. 1-7(7)

Publisher: Informa Healthcare

Determining Factors in the Prescription of Moxifloxacin in Exacerbations of Chronic Bronchitis in the Primary-Care Setting

Authors: Miravitlles, Marc; Llor, Carles

Source: Clinical Drug Investigation, Volume 27, Number 2, 2007 , pp. 95-104(10)

Publisher: Adis International

Antibiotic Treatment of Acute Respiratory Infections in Acute Care Settings

Authors: Gonzales, Ralph; Camargo, Carlos A.; MacKenzie, Thomas; Kersey, Ayanna S.; Maselli, Judith; Levin, Sara K.; McCulloch, Charles E.; Metlay, Joshua P.

Source: Academic Emergency Medicine, Volume 13, Number 3, March 2006 , pp. 288-294(7)

Publisher: Blackwell Publishing

Real-Life Treatment of Acute Exacerbations of Chronic Bronchitis with Moxifloxacin or Macrolides: A Comparative Post-Marketing Surveillance Study in General Practice

Authors: Schaberg, T.; Möller, M.; File, T.; Stauch, K.; Landen, H.

Source: Clinical Drug Investigation, Volume 26, Number 12, 2006 , pp. 733-744(12)

Publisher: Adis International

Comparison of the adverse event profiles of levofloxacin 500 mg and 750 mg in clinical trials for the treatment of respiratory infections

Authors: Khashab, Mohammed M.; Xiang, Jim; Kahn, James B.

Source: Current Medical Research and Opinion, Volume 22, Number 10, October 2006 , pp. 1997-2006(10)

Publisher: Informa Healthcare

Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones

Authors: Mensa, J.; Trilla, A.

Source: Clinical Microbiology & Infection, Volume 12, Supplement 3, May 2006 , pp. 42-54(13)

Publisher: Blackwell Publishing

Pharmacokinetic and Pharmacodynamic Aspects of Oral Moxifloxacin 400 mg/day in Elderly Patients with Acute Exacerbation of Chronic Bronchitis

Authors: Pea, Federico; Pavan, Federica; Lugatti, Emilio; Dolcet, Flavio; Talmassons, Giovanni; Maria Consuelo Screm,; Furlanut, Mario

Source: Clinical Pharmacokinetics, Volume 45, Number 3, 2006 , pp. 287-295(9)

Publisher: Adis International

Clarithromycin extended-release in community-acquired respiratory tract infections

Authors: Williams, Kathy N; Bishai, William R

Source: Expert Opinion on Pharmacotherapy, Volume 6, Number 16, 1 December 2005 , pp. 2867-2876(10)

Publisher: Informa Healthcare

Guide to Selection of Fluoroquinolones in Patients with Lower Respiratory Tract Infections

Authors: Shams, Wael E.; Evans, Martin E.

Source: Drugs, Volume 65, Number 7, 2005 , pp. 949-991(43)

Publisher: Adis International

3 days of azithromycin sufficient for bronchitis exacerbation

Source: Inpharma, Volume 1, Number 1484, 2005-04-23 , pp. 17-17(1)

Publisher: Adis International

Health-Related QOL in Acute Exacerbations of Chronic Bronchitis and Chronic Obstructive Pulmonary Disease: A Review of the Literature

Authors: Doll, Helen; Miravitlles, Marc

Source: PharmacoEconomics, Volume 23, Number 4, 2005 , pp. 345-363(19)

Publisher: Adis International

The quality of life impact of acute exacerbations of chronic bronchitis (AECB): A literature review

Authors: Schmier, Jordana; Halpern, Michael; Higashi, Mitchell; Bakst, Alan

Source: Quality of Life Research, Volume 14, Number 2, March 2005 , pp. 329-347(19)

Publisher: Springer